Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.

Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.

Item
http://www.wikidata.org/entity/Q34066022
Intermediate filaments: a historical perspectiveComparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cellsp53 gene mutations are not required for early dissemination of cancer cells.HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancerComparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment.Circulating Levels of M30 and M65 Molecules in Transitional Cell Carcinoma of the Bladder and Their Relation to Tumor Progression.Clinical significance of disseminated tumour cells in non-small cell lung cancerEvaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancerThe fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence.Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.Transcription of cytokeratins 8, 18, and 19 in bone marrow and limited expression of cytokeratins 7 and 20 by carcinoma cells: inherent limitations for RT-PCR in the detection of isolated tumor cells.Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma.Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients.Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
P2860

Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.

Item
http://www.wikidata.org/entity/Q34066022
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Epitope specificity of 30 mono ...... ens: the ISOBM TD5-1 Workshop.
@ast
Epitope specificity of 30 mono ...... ens: the ISOBM TD5-1 Workshop.
@en
Epitope specificity of 30 mono ...... ens: the ISOBM TD5-1 Workshop.
@nl
type
label
Epitope specificity of 30 mono ...... ens: the ISOBM TD5-1 Workshop.
@ast
Epitope specificity of 30 mono ...... ens: the ISOBM TD5-1 Workshop.
@en
Epitope specificity of 30 mono ...... ens: the ISOBM TD5-1 Workshop.
@nl
prefLabel
Epitope specificity of 30 mono ...... ens: the ISOBM TD5-1 Workshop.
@ast
Epitope specificity of 30 mono ...... ens: the ISOBM TD5-1 Workshop.
@en
Epitope specificity of 30 mono ...... ens: the ISOBM TD5-1 Workshop.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Epitope specificity of 30 mono ...... gens: the ISOBM TD5-1 Workshop
@en
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921